Stay updated on Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.
Latest updates to the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check35 days agoChange DetectedNew dates have been added for August 2024 and July to December 2025, while several November 2023 and July to December 2024 dates have been removed.SummaryDifference1%
- Check49 days agoChange DetectedThe study has been updated to version v2.10.0, with 5 locations now included, replacing the previous version v2.9.7.SummaryDifference0.4%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check70 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
Stay in the know with updates to Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.